Drug information for NEO-MEDROL
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
OINTMENT; OPHTHALMIC
0.1%;EQ 3.5MG BASE/GM
Discontinued
METHYLPREDNISOLONE
;
NEOMYCIN SULFATE
Neo-Medrol
PHARMACIA AND UPJOHN
60645
Drug Adverse Effects information for NEO-MEDROL
Role code
Indications
Reaction
# Reports
PS
BLEPHARITIS
DEAFNESS
1
PS
CONJUNCTIVITIS ALLERGIC
DEAFNESS
1
PS
INFLAMMATION
DEAFNESS
1
SS
BLEPHARITIS
DEAFNESS
1
SS
CONJUNCTIVITIS ALLERGIC
DEAFNESS
1
Ads by Google